Emcure Pharmaceuticals has announced the inauguration of its state-of-the-art Formulation Research and Development (R&D) Centre near Tapovan Circle, Ahmedabad. The Emcure Research Centre (ERC) is strategically designed to enable breakthroughs in complex drug delivery systems, such as sustained-release formulations, liposomal injections and advanced dermal therapies.
The landmark facility was inaugurated by Minister of Health and Family Welfare, Gujarat, Rushikeshbhai Patel, in a ceremony that marks Emcure’s commitment to advancing healthcare through cutting-edge research and transformative drug development.
The new ERC facility is designed to accelerate pharmaceutical innovation with state-of-the-art laboratories and advanced equipment for each of the dosage forms. From early-stage pre-formulation studies to scaling-up, the ERC seamlessly integrates all aspects of pharmaceutical development while adhering to global regulatory standards.
A team of 350 highly skilled professionals, including doctorate, post-graduate and graduate specialising in pharmaceutical sciences, bio-engineering, analytical chemistry, pharmacovigilance and regulatory affairs will work together to develop novel formulations, enhance drug bioavailability and create patient-centric delivery solutions.
With a focus on sustainable solutions and green chemistry practices, the Emcure Research Centre reflects the company’s dedication to environmentally conscious innovations. It also serves as a catalyst for job creation and collaborations with academic institutions, industry experts and regulatory bodies, promoting an ecosystem of shared knowledge and growth.
